<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cerebral hemodynamic action of <z:chebi fb="0" ids="9985">Vincamine</z:chebi> is measured in 17 patients with primary or secondary cerebral circulation disorders, by use of the multiregional 133Xe clearance technique </plain></SENT>
<SENT sid="1" pm="."><plain>The statistical analysis of the results justifies the grouping of <z:hpo ids='HP_0000001'>all</z:hpo> the cases and the distinction between reference, ischemic and hyperemic zones by determining for each subject a range of + or - 15% of his own mean regional cerebral blood flow </plain></SENT>
<SENT sid="2" pm="."><plain>The drug, in a single injection in the internal carotid artery, shows a significant beneficial hemodynamic effect on the ischemic regions of the brain </plain></SENT>
<SENT sid="3" pm="."><plain>No <z:e sem="disease" ids="C0853404" disease_type="Disease or Syndrome" abbrv="">steal phenomenon</z:e> is recorded in the middle cerebral artery territory </plain></SENT>
<SENT sid="4" pm="."><plain>The action of the drug leads to a decrease and an equalization of the hemodynamic resistances of the cerebral vascular bed </plain></SENT>
</text></document>